Promising COVID-19 Therapeutic Drug to start Phase 3 Clinical Trial in the United States
November 22, 2021 08:41 ET
|
Pulmonem Inc.
DIEPPE, New Brunswick, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Pulmonem Inc. and the Research Institute of the McGill University Health Centre today announced that they have successfully started...